Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Steven Keith Burke

Svp, Chief Medical Officer at Akebia Therapeutics, Inc. (AKBA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $94K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 4SEC AKBAAkebia Therapeutics, Inc. Sell Plan 21,582994,508 held (−2%) $1.39 $30K -51.8%
Feb 4SEC AKBAAkebia Therapeutics, Inc. Sell Plan 25,375969,133 held (−3%) $1.39 $35K -51.8%
Feb 4SEC AKBAAkebia Therapeutics, Inc. Sell Plan 20,701948,432 held (−2%) $1.39 $29K -51.8%
  • Sell

    Svp, Chief Medical Officer Steven Keith Burke sold $30K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp, Chief Medical Officer Steven Keith Burke sold $35K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp, Chief Medical Officer Steven Keith Burke sold $29K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.